Recyclable chiral catalyst for asymmetric nitroaldol reaction and process for the preparation thereof
US-2015368181-A1 · Dec 24, 2015 · US
US9950991B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9950991-B2 |
| Application number | US-201415033737-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 4, 2014 |
| Priority date | Nov 5, 2013 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a process for the preparation of Iopamidol of formula (II) and comprising the following steps: a) reacting the Compound (I) wherein X is OR2 or R3, and wherein R2 and R3 are a Ci-C6 linear or branched alkyl, C3-C6 cycloalkyl, C6 aryl, optionally substituted with a group selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, t-butyl and phenyl, with the acylating agent (S)-2-(acetyloxy)propanoyl chloride in a reaction medium to provide the acetyloxy derivative of Compound (I); b) hydrolyzing the intermediate from step a) with an aqueous solution at a pH comprised from 0 to 7, by adding water or a diluted alkaline solution such as sodium hydroxide or potassium hydroxide, freeing the hydroxyls from the boron-containing protective groups, obtaining the N—(S)-2-(acetyloxy)propanoyl derivative of Compound (II); c) alkaline hydrolysis to restore the (S)-2-(hydroxy)propanoyl group and to obtain Iopamidol (II) and optional recovery of the boron derivative from the solution obtained in step b). The boron-containing protective group is versatile, efficient and recyclable. A one-pot synthesis, without intermediate isolation is provided, leading to a decreasing of recovered and recycled solvents and a significant increasing in the yield, representing a significant advantage in terms of cost-effectiveness of the entire process and environmental awareness.
Opening claim text (preview).
The invention claimed is: 1. A process for preparation of Iopamidol (II) comprising the following reaction: wherein X is OR 2 or R 3 , and wherein R 2 and R 3 are individually a C 1 -C 6 linear or branched alkyl, C 3 -C 6 cycloalkyl, or C 6 aryl, optionally substituted with a group selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, t-butyl, and phenyl; and comprising the following steps: a) reacting Compound (I) with an acylating agent (S)-2-(acetyloxy)propanoyl chloride in a reaction medium to provide an intermediate, N—(S)-2-(acetyloxy)propanoyl derivative of Compound (I); b) hydrolyzing the intermediate from step a) with an aqueous solution at a pH from 6 to 7 comprising: adding water or a diluted alkaline solution, freeing hydroxyls from the boron-containing protective groups, obtaining an aqueous mixture of an acetyloxy derivative of Iopamidol (II) and a boron-derivative, and optionally recovering the boron-derivative; and c) hydrolyzing the acetyloxy derivative of Iopamidol (II) to obtain Iopamidol (II). 2. The process according to claim 1 , wherein X is OR 2 . 3. The process according to claim 1 , wherein X is R 3 . 4. The process according to claim 1 , wherein said reaction medium in step a) is an anhydrous organic solvent. 5. The process according to claim 1 , wherein said reaction medium in step a) is selected from the group consisting of N,N-dimethylformamide, N,N-dimethylacetamide, N,N-diethylacetamide, N,N-dimethylpropionamide, N-methylpyrrolidone N-ethylpyrrolidone, tetramethylurea, N,N′-dimethylethyleneurea (DMEU), and N,N′-dimethylpropyleneurea (DMPU), optionally in an admixture with a co-solvent. 6. The process according to claim 1 , wherein in step b) the optional recovering of the boron-derivative is carried out by chromatography or by co-solvent extraction. 7. The process according to claim 1 , wherein said Compound (I) is prepared starting from a Compound of formula (IV), according to the following reaction: and comprising: reacting the Compound of formula (IV) with a boric acid in an R 2 OH alcohol or a borate ester B(OR 2 ) 3 , to provide the Compound of formula (I), wherein X is OR 2 ; or reacting the Compound of formula (IV) with a boronic acid R 3 —B(OH) 2 or a boroxine of formula (III): to provide the Compound of formula (I), wherein X is R 3 . 8. The process according to claim 7 , wherein the borate ester B(OR 2 ) 3 is used. 9. The process according to claim 8 , wherein the borate ester B(OR 2 ) 3 is selected from the group consisting of tri-n-butyl borate, tri-n-propyl borate, and tri-ethyl borate. 10. The process according to claim 7 , wherein said Compound (I) is prepared by reacting the Compound of formula (IV) with the boronic acid R 3 —B(OH) 2 or the boroxine (III). 11. The process according to claim 10 , wherein the boronic acid R 3 —B(OH) 2 is selected from the group consisting of phenylboronic acid, tolylboronic acid, and butylboronic acid; and the boroxine of formula (III) is selected from the group consisting of tri-phenylboroxine and tri-methylboroxine. 12. The process according to claim 10 , which comprises recovering the boron-derivative by a co-solvent extraction with a co-solvent, wherein said co-solvent is an organic water-immiscible solvent selected from the group consisting of 4-methyl-2-pentanone, 2-pentanone, 3-pentanone, dibutyl ether, 2-methyl-tetrahydrofurane, ciclopentylmethyl ether, methyl isopropyl ketone, methyl isopentyl ketone, ethyl acetate, butyl acetate, pentyl acetate, isopentyl acetate, and isopropyl acetate. 13. The process according to claim 1 , which is a one-pot process. 14. The process according to claim 7 , wherein said Compound of formula (IV) is prepared by iodinating Compound (V): 15. The process according to claim 14 , wherein said Compound (V) is prepared according to the following reaction scheme: wherein: i) the 5-nitroisophthalic acid (5-NIPA) is treated with an R 1 OH alcohol, wherein R 1 is a linear or branched C 1 -C 4 alkyl, to provide the corresponding diester (VI); ii) the 5-nitro group of the diester (VI) is reduced to the corresponding 5-amino group to provide the Compound (VII); and iii) the two ester groups of Compound (VII) are reacted with 2-amino-1,3-propandiol to provide the Compound (V). 16. A process for the preparation of Iopamidol (II) according to the following reaction scheme: wherein X is OR 2 or R 3 , and wherein R 2 and R 3 are individually a C 1 -C 6 linear or branched alkyl, C 3 -C 6 cycloalkyl, or C 6 aryl, optionally substituted with a group selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, t-butyl, and phenyl, comprising: i) treating the 5-nitroisophthalic acid (5-NIPA) with an R 1 OH alcohol, wherein R 1 is a linear or branched C 1 -C 4 alkyl, to provide the diester (VI); ii) reducing the 5-nitro group of the diester (VI) to provide the Compound (VII); iii) reacting the two ester groups of Compound (VII) with 2-amino-1,3-propandiol to provide the Compound (V), 5-Amino-N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-1,3-benzenedicarboxamide; iv) iodinating the Compound (V) at positions 2, 4, 6, to provide the Compound (IV), 5-Amino-N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide; v) treating the Compound (IV) with a boronic acid R 3 —B(OH) 2 , a borate ester B(OR 2 ) 3 , or a boroxine of formula (III), to provide the Compound of formula (I); and vi) transforming the Compound of formula (I) into Iopamidol (II) according to claim 1 . 17. The process according to claim 1 , further comprising isolating and purifying Iopamidol (II). 18. The process according to claim 17 , wherein said purifying step is to pharmaceutical grade. 19. A Compound of formula (I) wherein X is OR 2 or R 3 , and wherein R 2 and R 3 are individually a C 1 -C 6 linear or branched alkyl, C 3 -C 6 cycloalkyl, or C 6 aryl, optionally substituted with a group selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, t-butyl, and phenyl. 20. The Compound of claim 19 , wherein X is selected from the group consisting of phenyl, methyl substituted phenyl, methyl, and butyl. 21. The Compound of claim 20 , wherein X is phenyl. 22. A method of converting Compound of formula (I) to an intermediate, N—(S)-2-(acetyloxy)propanoyl derivative of Compound (I), comprising reacting Compound (I)
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title
Esters of boric acids · CPC title
by reactions not involving the formation of nitro groups · CPC title
from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title
by reactions not involving the formation of carboxamide groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.